1Enneking W F,Dunham W,Gebhardt M C,et al.A system for the functional evaluation of reconstructire procedures after surgical treatment of tumors ofthe musculoskeletal system[J].Clin Orthop Relat Res,1993,286(1):241-246.
1Bacci G, Lari S. Current treatment of high grade osteosarcoma of the extremity[J].J Chemother, 2001, 13(3): 235～243.
2Uchida A. Recent advances in management of musculoskeletal tumors[J]. Cancer chemother, 1999, 26(Suppl): 185～190.
3Patel SJ, LynchJWJr, Johnson T, et al. Dose-intense ifosfamide/doxorubicin/cisplatin based chemotherapy for osteosarcoma in adults[J]. AmJ Clin Oncol, 2002, 25(5): 489～495.
4Goorin AM, Schwartzentruber DJ, Devidas M, et al. Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study[J].J Clin Oncol, 2003, 21(8): 1574～1580.
5Reddick WE, Wang S, Xiong X, et al. Dynamic magnetic resonance imaging of regional contrast access as an additional prognostic factor in pediatric osteosarcoma [J]. Cancer, 2001, 91 (12):2230～2237.
6Bacci G, Forni C, Ferrari S, et al. Neoadjuvant chemotherapy for osteosarcoma of the extremity: intensification of preoperative treatment does not increase the rate of good histologic response to the primary tumor or improve the final outcome [J]. J Pediatr Hematol Oncol, 2003, 25(11): 845～853.
7Scotland K, Baldni N, Serra M, et al. Adriamycin binding assay:avaluable chemosensitivity test in human osteosarcoma[J]. J Cancer Res Clin Oncol, 1992, 119:121～126.
8Baldini N, Scotlandi K, Serra M, et al. P-glycoprotein expression in osteosarcoma: a basis for risk-adapted adjuvant chemotherapy [J].J Orthop Res, 1999, 17(5): 629～632.
9Serra M, Scodandi K, Reverter-Branchat G, et al. Value of Pglycoprotein and linicopathologic factors as the basis for new treatment strategies in high-grade osteosarcoma of the xtremities [J].J Clin Oncol, 2003, 21(3): 536～542.
10Ifergan I, Meller I, IssakovJ, et al. Reduced folate carrier protein expression in osteosarcoma: implications for the prediction of tumor chemosensitivity[J]. Cancer, 2003, 98(9): 1958～1966.
